The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)
The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)
Recruiting · NCT07064681 · Registry updated 2025-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING) | Resectable Hepatocellular Carcinoma With High Risk of Recurrence | Recruiting | Not stated | 2025-07-15 | NCT07064681 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-sen University | 606 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The first affiliated hospital of SYSU | Guangzhou | China | 1 |